Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohort

被引：2

作者：

Shah, Shailja ^{[1
,2
]}

Halvorson, Alese ^{[3
]}

McBay, Brandon ^{[4
]}

Dorn, Chad ^{[5
]}

Wilson, Otis ^{[6
,7
]}

Tuteja, Sony ^{[8
,9
]}

Chang, Kyong-Mi ^{[8
,9
]}

Cho, Kelly ^{[10
,11
]}

Hauger, Richard ^{[12
,13
]}

Suzuki, Ayako ^{[14
,15
]}

Hunt, Christine ^{[14
,15
]}

Siew, Edward ^{[7
,16
]}

Matheny, Michael ^{[5
,7
,16
]}

Hung, Adriana ^{[6
,16
]}

Greevy, Robert ^{[3
,6
]}

Roumie, Christianne ^{[6
,17
,18
]}

机构：

[1] VA San Diego Healthcare Syst, Gastroenterol Sect, San Diego, CA USA

[2] Univ Calif San Diego, Div Gastroenterol, San Diego, CA 92103 USA

[3] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA

[4] Harvard Univ TH Chan Sch Publ Hlth, Dept Publ Hlth, Boston, MA USA

[5] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA

[6] VA Tennessee Valley, Clin Serv Res & Dev, Nashville, TN USA

[7] VA Tennessee Valley, Hlth Serv Res & Dev, Nashville, TN USA

[8] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA

[9] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[10] VA Boston Healthcare Syst, Boston, MA USA

[11] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[12] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA

[13] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA

[14] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA

[15] Durham VA Hlth Care Syst, Gastroenterol Sect, Durham, NC USA

[16] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN USA

[17] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA

[18] VA Tennessee Valley Hlth Syst, VA Geriatr Res Educ & Clin Ctr GRECC, Nashville, TN USA

来源：

GUT | 2022年 / 71卷 / 07期

关键词：

proton pump inhibition; COVID-19; epidemiology; SARS-COV-2 RELATED OUTCOMES;

D O I：

10.1136/gutjnl-2021-325701

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1447 / 1450

页数：4

共 24 条

[1] Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
Lee, Seung Won
Ha, Eun Kyo
Yeniova, Abdullah Ozgur
Moon, Sung Yong
Kim, So Young
Koh, Hyun Yong
Yang, Jee Myung
Jeong, Su Jin
Moon, Sun Joon
Cho, Joo Young
Yoo, In Kyung
Yon, Dong Keon
GUT, 2021, 70 (01) : 76 - 84
[2] Proton-pump inhibitor use is not associated with adverse clinical outcomes of COVID-19: A territory-wide cohort study of 8675 patients
Yip, Terry Cheuk-Fung
Chan, Francis Ka-Leung
Lui, Grace Chung-Yan
Wong, Vincent Wai-Sun
Chan, Henry Lik-Yuen
Wong, Sunny Hei
Mak, Joyce Wing-Yan
Ng, Siew-Chien
Hui, David Shu-Cheong
Wong, Grace Lai-Hung
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 47 - 48
[3] Proton Pump Inhibitor Use and Associated Infectious Complications in the PICU: Propensity Score Matching Analysis
Goyer, Isabelle
Lacotte, Edouard
Montreuil, Julien
Thibon, Pascal
Briant, Anais R.
Dupont, Claire
Parienti, Jean-Jacques
Brossier, David
PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (12) : E590 - E594
[4] Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study
Zhou, Jiandong
Wang, Xiansong
Lee, Sharen
Wu, William Ka Kei
Cheung, Bernard Man Yung
Zhang, Qingpeng
Tse, Gary
GUT, 2021, 70 (10) : 2012 - +
[5] Association Between Proton Pump Inhibitor Use and COVID-19 Related Hospitalization Outcomes
Wong, Danny
Bazarbashi, Ahmad Najdat
Hathorn, Kelly E.
McCarty, Thomas R.
Redd, Walker D.
Zhou, Joyce C.
Njie, Cheikh
Lo, Wai-Kit
Shen, Lin
Chan, Walter W.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S689 - S689
[6] NO ASSOCIATION BETWEEN PROTON-PUMP INHIBITOR USE AND ADVERSE CLINICAL OUTCOMES OF COVID-19: A TERRITORY-WIDE COHORT STUDY OF 8,675 PATIENTS
Yip, Terry Cheuk-Fung
Chan, Francis Ka-Leung
Lui, Grace Chung-Yan
Wong, Vincent Wai-Sun
Chan, Henry Lik-Yuen
Hei-Wong, Sunny
Mak, Joyce Wing-Yan
Ng, Siew-Chien
Hui, David Shu-Cheong
Wong, Grace Lai-Hung
GUT, 2021, 70 : A9 - A10
[7] Proton Pump Inhibitor Use and Recurrent Clostridium difficile-associated Disease A Case-control Analysis Matched by Propensity Score
Kim, Yong Gil
Graham, David Y.
Jang, Byung Ik
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (05) : 397 - 400
[8] Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score
Johnson, Eric K.
DISEASES OF THE COLON & RECTUM, 2012, 55 (10) : E352 - E352
[9] Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Freedberg, Daniel E.
Conigliaro, Joseph
Wang, Timothy C.
Tracey, Kevin J.
Callahan, Michael V.
Abrams, Julian A.
GASTROENTEROLOGY, 2020, 159 (03) : 1129 - +
[10] The Risk of Spontaneous Bacterial Peritonitis Associated With Proton Pump Inhibitor Use in Cirrhotic Patients With Ascites: Long-Term Outcome in the Propensity Score-Matched Cohort
Lim, Kyung Suk
Min, Yang Won
Min, Byung Hoon
Gwak, Geum-Youn
Paik, Yong Han
Lee, Jun Haeng
Choi, Moon Seok
Lee, Joon Hyoek
Kim, Jae J.
Koh, Kwang Cheol
Paik, Seung Woon
Yoo, Byung Chul
Rhee, Poong-Lyul
GASTROENTEROLOGY, 2014, 146 (05) : S991 - S991

← 1 2 3 →